Special issue: Hepatitis C virus. Natural history and treatment of type C hepatitis.
نویسندگان
چکیده
منابع مشابه
[Natural history of hepatitis C virus infection].
Over 70% of individuals acutely infected with hepatitis C virus (HCV) develop chronic infection at significant risk of progressive liver fibrosis and subsequent liver cirrhosis and hepatocellular carcinoma. Various viral, host, and environmental factors have been reported to affect the natural history of HCV infection such as chronicity in acute phase and disease progression in chronic phase. R...
متن کاملNatural history of hepatitis C virus infection
The natural history of hepatitis C virus infection is still unclear. This disease has a long clinical latency period and very frequently develops into chronic forms (in 70-80% of cases). Diagnosis of chronic HCV infection can only be based on liver biopsy. Histological scores permit rating disease severity and to compare successive biopsy specimens. Certain clinical peculiarities deserve to be ...
متن کاملHepatitis C virus and skin
Nowadays viral hepatitis is one of the most common and important causes of chronic liver disorders in the world. Extrahepatic manifestations of viral hepatitis consist a main part of the disease. The main viruses causing hepatitis include Hepatitis A, B and C viruses. Herein common skin manifestations in hepatitis C virus (HCV) are discussed. Chronic hepatitis causes skin disorders both directl...
متن کاملNatural history of hepatitis C.
With advances in tools for the diagnosis of hepatitis C virus (HCV) infection, it has become easier to evaluate the natural course of hepatitis C. Although HCV infection initially occurs in adult individuals, in most patients with acute hepatitis C (68%) it develops into chronic hepatitis. Once chronic hepatitis is established, the rate of spontaneous cure of the liver disease is very rare (bel...
متن کاملHepatitis C Virus and Vaccine Development
The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Uirusu
سال: 1993
ISSN: 0042-6857,1884-3433
DOI: 10.2222/jsv.43.2_327